Cholesterol Clinical Trial
Official title:
Cholesterol Mobilization and Adipocyte Function in Humans
Hypothesis: increasing dietary cholesterol in humans will increase visceral, but not
subcutaneous adipocyte size, free cholesterol content, and inflammatory gene expression.
Visceral and abdominal subcutaneous adipose tissue biopsies will be obtained from non-obese
subjects undergoing elective abdominal surgery at Wake Forest Baptist Medical Center after 3
weeks of zero (control) or 1g dietary cholesterol supplementation. Blood samples will also be
taken before and after 3 weeks of dietary supplementation (0 vs. 1g dietary cholesterol) to
measure plasma lipids levels, and ex vivo monocyte chemotaxis. Blood will also be used to
isolate CD14+ monocytes for RNA extraction and storage for future transcriptome studies.
Measurements of adipocyte size, free cholesterol content, and inflammatory gene and protein
expression in the adipose tissue biopsies to test the hypothesis. Adipocytes and the stromal
vascular fraction will be isolated and evaluated for CD14+ macrophages for RNA extraction and
storage for future transcriptome analysis.
A Wake Forest School of Medicine Clinical Research Unit-based pilot study will be conducted in which subjects scheduled to undergo elective intra-abdominal surgery at Wake Forest Baptist Medical Center (i.e., cholecystectomy, Nissen fundoplication, hernia repair, etc.) will be recruited. Subjects will be randomly and blindly assigned to receive daily treats (cookie, brownie, or muffin) containing either no added cholesterol (control) or 1g of cholesterol/day (~0.4 mg/Kcal cholesterol) for 3 weeks prior to surgery. Three weeks for the length of cholesterol supplementation has been chosen because this is within the duration of human egg-consumption studies in which significant elevations in plasma LDL concentrations occurred. A blood sample will be taken from each participant at baseline before starting the supplementation period and after 3 weeks of 0 or 1g/day cholesterol supplementation, at the time of scheduled surgery. The blood samples will be used for measurement of lipid profile, ex vivo monocyte chemotaxis, and for monocyte RNA isolation. During surgery, abdominal wall subcutaneous adipose tissue and mesenteric (visceral) adipose tissue samples will be obtained. Aliquots of adipose tissue will be fixed overnight for histology and measurement of adipocyte size distribution and CD68 immunostaining, flash frozen and stored for cholesterol quantification by gas liquid chromatography, extracted to isolate RNA and protein for quantitative real time PCR and immunoblotting of inflammatory gene and protein expression, and collagenase digested to isolate adipocytes and stromal vascular cell fraction macrophages which will be used to extract and store RNA for future transcriptome analyses. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05218980 -
Health-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For Health
|
N/A | |
| Recruiting |
NCT05050266 -
Enhancing Mental and Physical Health of Women Veterans
|
N/A | |
| Completed |
NCT04114916 -
Clinical Trial to Evaluate the Reduction of Cardiovascular Risk
|
N/A | |
| Completed |
NCT00653276 -
MD Ezetimibe Cyclosporine Interaction (0653-057)
|
Phase 1 | |
| Recruiting |
NCT04546126 -
Positron Emission Tomography (PET) Imaging of Cholesterol Trafficking: Clinical Evaluation of [18F]FNP-59 in Normal Human Subjects (Groups 2, 3 & 4)
|
Early Phase 1 | |
| Completed |
NCT05267301 -
AlmegaPL CV Health Open Label Study
|
Phase 4 | |
| Completed |
NCT02259153 -
Effect of Different Fat Enriched Meats on the Hepatic Cholesterol Synthesis
|
N/A | |
| Completed |
NCT02169245 -
Effects of Protein and Fiber at Breakfast on Appetite, Blood Sugar, and Cholesterol
|
N/A | |
| Recruiting |
NCT01890889 -
Study of Changes in Total Cholesterol Levels as a Function of Consuming a Supplement Designed to Improve Cardiovascular Health
|
N/A | |
| Completed |
NCT00652301 -
A Research Study to Evaluate MK0653 (Ezetimibe) and Simvastatin, Given Together and Alone, on Intestinal Absorption of Cholesterol (0653-050)(COMPLETED)
|
Phase 3 | |
| Completed |
NCT01239914 -
CathOlic Medical Center percutAneous Coronary inTervention Registry (COACT)
|
||
| Recruiting |
NCT04532489 -
Positron Emission Tomography (PET) Imaging of Cholesterol Trafficking: Clinical Evaluation of [18F]FNP-59 in Normal Human Subjects (Group 1)
|
Early Phase 1 | |
| Completed |
NCT03985917 -
Singing Groups for Seniors: Well-Being, Cognitive Function and Health
|
N/A | |
| Completed |
NCT01494298 -
Study of Cholesterol Levels and Types in African Americans With Type 2 Diabetes
|
N/A |